A new device to boost radiotherapy during brain tumor surgery
Part of Cancer clinical trials.
This study tests a medical device that is placed in the brain during tumor removal surgery. It aims to trap any remaining tumor cells and make radiotherapy more effective. Participants will receive standard treatment plus this device.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 69 years old.
- You have a newly diagnosed, single brain tumor (likely high-grade glioma) that is not in the back of the brain or too close to critical areas.
- You are scheduled for surgery to remove at least 90% of the tumor.
- You are able to have an MRI with contrast dye.
- You are generally able to care for yourself (performance status 0-2).
- You agree to use birth control during the study and for 6 months after treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether Tumor Treating Fields (a wearable electrical device placed on the scalp) combined with temozolomide can treat brainstem gliomas (tumors in key parts of the brainstem). It may help slow tumor growth and improve outcomes for adults who have already finished surgery/radiation or are otherwise ready for the next treatment step.
This study tests a special imaging device (GLOW400) used during brain surgery for high-grade glioma. The device works with a fluorescent dye (5-ALA) to help the surgeon see the tumor more clearly, which may improve removal of the tumor while protecting healthy brain tissue.
This early-phase trial tests a tiny implanted device placed during brain tumor surgery. It delivers very small doses of medicine directly to the tumor area for a short time, aiming to see if this approach is safe and workable in patients with certain gliomas.
This trial tests a dye that makes brain tumor tissue glow under a special light during surgery, helping the surgeon see and remove more of the tumor while sparing healthy brain. It is for people with newly diagnosed high-grade glioma (a fast-growing brain tumor) who are scheduled for their first surgery to remove the tumor.
This early-phase study tests a type of very targeted radiation given before surgery for people with a high-grade (aggressive) brain tumor. The goal is to see if this approach is safe and potentially improves treatment, while collecting tumor and blood samples for research.
This trial tests a special radiation boost that targets low-oxygen areas of the brain tumor during standard radiation therapy. It may help control the tumor better for people with newly diagnosed or recurrent glioblastoma.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.